Short Daily Versus Conventional Hemodialysis for COVID-19 Patients

Short Daily Versus Conventional Hemodialysis for COVID-19 Patients: A Randomized Study

Treatment of dialysis patients involved with COVID-19 with short daily hemodialysis has been supposed to improve short term outcome. It is unclear if short daily dialysis would optimize mortality or ICU admission in routine dialysis patients with COVID-19.

Also the potential variants according with worse outcomes remain to be fully elucidated.

investigators undertook a randomized trial in ESRD patients infected with COVID-19 to determine: 1) if short-daily hemodialysis is associated with a reduction in mortality and ICU admission in one weak period and; 2) the potential effective variants in worst outcome. . Paperwork for the trial was submitted to the shaheed beheshti university of medical sciences in June 2021 for registration . The protocol for this trial and supporting CONSORT checklist are available. The SBMU Ethics Board approved the study and all amendments. The study was conducted according to the Declaration of Helsinki.

Inclusion Criteria:

• ESRD patients >3months on hemodialysis admitted for COVID-19

Exclusion Criteria:

• ESRD patients <3 months on hemodialysis infected with COVID-19